# Evaluation of a Preventive Therapeutic Strategy for Postpartum Venous Thromboembolism in Women With Genetic Risk Factor

> **NCT07342127** · — · COMPLETED · sponsor: **Hospices Civils de Lyon** · enrollment: 86 (actual)

## Conditions studied

- Factor V Leiden Heterozygous Mutation
- Factor II Heterozygous Mutation
- Pregnancy
- Postpartum

## Interventions

- **OTHER:** Retrospective collection of health data
- **OTHER:** Phone call to every participant

## Key facts

- **NCT ID:** NCT07342127
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2026-02-04
- **Primary completion:** 2026-03-13
- **Final completion:** 2026-03-13
- **Target enrollment:** 86 (ACTUAL)
- **Last updated:** 2026-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07342127

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07342127, "Evaluation of a Preventive Therapeutic Strategy for Postpartum Venous Thromboembolism in Women With Genetic Risk Factor". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07342127. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*